Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Share price down 1.6%

0

Fresenius Medical Care AG & Co. KGaA (New York Stock Exchange: FMSGet a rating) shares were down 1.6% in midday trading on Monday. The stock traded as low as $23.03 and last traded at $23.09. Around 3,445 shares changed hands during the midday session, down 99% from the average daily volume of 568,697 shares. The stock previously closed at $23.46.

Changes to analyst ratings

Several equity analysts have published reports on FMS shares. JPMorgan Chase & Co. raised its price target on shares of Fresenius Medical Care AG & Co. KGaA from €48.70 ($49.19) to €51.00 ($51.52) and assigned the company an “underweight” rating in a Thursday, May 5 research note. . StockNews.com cut shares of Fresenius Medical Care AG & Co. KGaA from a “strong buy” rating to a “buy” rating in a Friday, July 15 research note. Truist Financial lowered its price target on shares of Fresenius Medical Care AG & Co. KGaA from $34.00 to $27.00 and set a “hold” rating on the stock in a Wednesday research note June 22. Finally, Jefferies Financial Group downgraded shares of Fresenius Medical Care AG & Co. KGaA from an “underperforming” rating to a “buy” rating and raised its price target for the company from $30.30 to $33.70 in a Monday, June 27 research note. One financial analyst has assigned the stock a sell rating, six have issued a hold rating and five have assigned the stock a buy rating. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $52.51.

Fresenius Medical Care AG & Co. KGaA Stock up 2.8%

The company has a debt ratio of 0.51, a quick ratio of 0.93 and a current ratio of 1.26. The company’s 50-day moving average is $26.81 and its 200-day moving average is $30.72. The company has a market capitalization of $13.71 billion, a PE ratio of 13.37, a growth price-earnings ratio of 0.94 and a beta of 1.21.

Fresenius Medical Care AG & Co. KGaA (New York Stock Exchange: FMSGet a rating) last released its quarterly earnings data on Wednesday, May 4. The company reported EPS of $0.38 for the quarter, beating the consensus estimate of $0.30 by $0.08. Fresenius Medical Care AG & Co. KGaA achieved a net margin of 4.91% and a return on equity of 6.99%. The company posted revenue of $5.10 billion for the quarter, versus analyst estimates of $4.97 billion. As a group, research analysts expect Fresenius Medical Care AG & Co. KGaA to post earnings per share of 1.98 for the current fiscal year.

Fresenius Medical Care AG & Co. KGaA reduces its dividend

The company also recently announced an annual dividend, which was paid on Friday, May 27. Shareholders of record on Monday, May 16 received a dividend of $0.7093. The ex-dividend date was Friday, May 13. This represents a return of 3.4%. The dividend payout ratio (DPR) of Fresenius Medical Care AG & Co. KGaA is 28.00%.

Institutional entries and exits

A number of institutional investors and hedge funds have recently increased or reduced their stake in FMS. Russell Investments Group Ltd. bought a new position in Fresenius Medical Care AG & Co. KGaA in Q4, valued at approximately $1,152,000. Ellevest Inc. increased its shareholding in Fresenius Medical Care AG & Co. KGaA by 96.6% during the 4th quarter. Ellevest Inc. now owns 1,148 shares of the company worth $37,000 after acquiring an additional 564 shares during the period. Janney Montgomery Scott LLC increased its equity stake in Fresenius Medical Care AG & Co. KGaA by 7.1% during the 4th quarter. Janney Montgomery Scott LLC now owns 31,996 shares of the company worth $1,039,000 after acquiring 2,114 additional shares during the period. Commonwealth Equity Services LLC increased its equity stake in Fresenius Medical Care AG & Co. KGaA by 6.4% during the 4th quarter. Commonwealth Equity Services LLC now owns 13,583 shares of the company worth $440,000 after acquiring 817 additional shares during the period. Finally, Timber Creek Capital Management LLC increased its equity stake in Fresenius Medical Care AG & Co. KGaA by 5.5% during the 4th quarter. Timber Creek Capital Management LLC now owns 189,048 shares of the company worth $6,136,000 after acquiring an additional 9,910 shares during the period. 4.73% of the shares are currently held by hedge funds and other institutional investors.

About Fresenius Medical Care AG & Co. KGaA

(Get a rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

Read more



Get news and reviews for Fresenius Medical Care AG & Co. KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com’s free daily email newsletter .

Share.

Comments are closed.